Furthermore, a deeper understanding of the distinct roles and dynamics of FKBP51 isoforms offers the potential for more precise interventions in stress-related diseases, including metabolic dysfunctions, which are significant comorbidities in depression and arise as side effects of the commonly used psychopharmacological treatments. The gene discussed is FKBP5; the disease is major depressive disorder.